194 related articles for article (PubMed ID: 32952126)
41. Long isoform of ErbB3 binding protein, p48, mediates protein kinase B/Akt-dependent HDM2 stabilization and nuclear localization.
Kim CK; Lee SB; Nguyen TL; Lee KH; Um SH; Kim J; Ahn JY
Exp Cell Res; 2012 Jan; 318(2):136-43. PubMed ID: 21930127
[TBL] [Abstract][Full Text] [Related]
42. Aberrant DNA methylation defines isoform usage in cancer, with functional implications.
Chen YC; Elnitski L
PLoS Comput Biol; 2019 Jul; 15(7):e1007095. PubMed ID: 31329578
[TBL] [Abstract][Full Text] [Related]
43. Expression, purification, crystallization and preliminary crystallographic analysis of the proliferation-associated protein Ebp1.
Kowalinski E; Bange G; Wild K; Sinning I
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Sep; 63(Pt 9):768-70. PubMed ID: 17768350
[TBL] [Abstract][Full Text] [Related]
44. A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis.
Yamamoto M; Torigoe T; Kamiguchi K; Hirohashi Y; Nakanishi K; Nabeta C; Asanuma H; Tsuruma T; Sato T; Hata F; Ohmura T; Yamaguchi K; Kurotaki T; Hirata K; Sato N
Cancer Res; 2005 Oct; 65(19):8706-14. PubMed ID: 16204039
[TBL] [Abstract][Full Text] [Related]
45. YC-1 Antagonizes Wnt/β-Catenin Signaling Through the EBP1 p42 Isoform in Hepatocellular Carcinoma.
Wu JY; Shih YL; Lin SP; Hsieh TY; Lin YW
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31086087
[TBL] [Abstract][Full Text] [Related]
46. C-terminal domain of p42 Ebp1 is essential for down regulation of p85 subunit of PI3K, inhibiting tumor growth.
Hwang I; Kim CK; Ko HR; Park KW; Cho SW; Ahn JY
Sci Rep; 2016 Jul; 6():30626. PubMed ID: 27464702
[TBL] [Abstract][Full Text] [Related]
47. DAXX in cancer: phenomena, processes, mechanisms and regulation.
Mahmud I; Liao D
Nucleic Acids Res; 2019 Sep; 47(15):7734-7752. PubMed ID: 31350900
[TBL] [Abstract][Full Text] [Related]
48. ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer.
Yang IS; Son H; Kim S; Kim S
BMC Genomics; 2016 Aug; 17(1):631. PubMed ID: 27519173
[TBL] [Abstract][Full Text] [Related]
49. ErbB3 binding protein 1 (EBP1) participates in the regulation of intestinal inflammation via mediating Akt signaling pathway.
Miao X; Tang Q; Miao X; Wu Y; Qian J; Zhao W; Wang L; Li L; Zhang D
Mol Immunol; 2015 Oct; 67(2 Pt B):540-51. PubMed ID: 26256794
[TBL] [Abstract][Full Text] [Related]
50. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin.
Yoo JY; Wang XW; Rishi AK; Lessor T; Xia XM; Gustafson TA; Hamburger AW
Br J Cancer; 2000 Feb; 82(3):683-90. PubMed ID: 10682683
[TBL] [Abstract][Full Text] [Related]
51. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
[TBL] [Abstract][Full Text] [Related]
52. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells.
Song L; Wang L; Li Y; Xiong H; Wu J; Li J; Li M
J Pathol; 2010 Nov; 222(3):227-37. PubMed ID: 20662004
[TBL] [Abstract][Full Text] [Related]
53. Mass spectrometric analysis of post-translational modifications (PTMs) and protein-protein interactions (PPIs).
Ngounou Wetie AG; Woods AG; Darie CC
Adv Exp Med Biol; 2014; 806():205-35. PubMed ID: 24952184
[TBL] [Abstract][Full Text] [Related]
54. EBP1 suppresses growth, migration, and invasion of thyroid cancer cells through upregulating RASAL expression.
Liu H; Li Z; Li L; Peng H; Zhang Z
Tumour Biol; 2015 Nov; 36(11):8325-31. PubMed ID: 26008146
[TBL] [Abstract][Full Text] [Related]
55. RNA-binding proteins, multifaceted translational regulators in cancer.
Wurth L; Gebauer F
Biochim Biophys Acta; 2015 Jul; 1849(7):881-6. PubMed ID: 25316157
[TBL] [Abstract][Full Text] [Related]
56. Analysis of the expression pattern of Ebp1, an ErbB-3-binding protein.
Xia X; Lessor TJ; Zhang Y; Woodford N; Hamburger AW
Biochem Biophys Res Commun; 2001 Nov; 289(1):240-4. PubMed ID: 11708806
[TBL] [Abstract][Full Text] [Related]
57. Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signaling for cell proliferation.
Kwon NH; Lee MR; Kong J; Park SK; Hwang BJ; Kim BG; Lee ES; Moon HG; Kim S
RNA Biol; 2018; 15(4-5):635-648. PubMed ID: 28816616
[TBL] [Abstract][Full Text] [Related]
58. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
59. Targeting the RNA-binding protein Sam68 as a treatment for cancer?
Lukong KE; Richard S
Future Oncol; 2007 Oct; 3(5):539-44. PubMed ID: 17927519
[TBL] [Abstract][Full Text] [Related]
60. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
Goel RK; Lukong KE
Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
